牛乳免疫球蛋白和补体含量测定

用琼脂单项免疫扩散法测定牛乳免疫球蛋白和补体含量。结果表明：初乳免疫球蛋白和补体Ｃ３含量极显著高于常乳（Ｐ〈０．０１）;初乳补体Ｃ４含量显著高于常乳（Ｐ〈０．０５）;初乳中免疫球蛋白和补体含量于产后３天达到高峰。     

从进口冻鸡爪中检出鸡白痢沙门氏菌

2001年12月,南海某公司从美国进口一批冻鸡爪,我局按规定进行抽样检验,经细菌分离培养和生化试验,确定该批货物含鸡白痢沙门氏菌.     

蚕蛹蛋白水解技术研究进展

目前蚕业资源综合利用正作为一个新兴产业得到广泛关注。蚕蛹是缫丝过程中的副产物,富含蛋白质,含有人体需要的18种氨基酸,其中8种必需氨基酸含量达40%以上,其组成和比例非常符合WHO/FAO提出的氨基酸模式,是优质蛋白质及氨基酸来源。我国每年有10多万吨干蚕蛹可供利用,但大多被     

漳浦县中蜂高产措施

养中蜂最主要的目的是追求蜂蜜产量.目前国内有关中蜂技术较全面、系统的著作有杨冠煌老师的<中华蜜蜂>和龚凫羌先生的<中蜂饲养原理与方法>.但至今尚未见到有相当规模的示范蜂场的报道.我的技术措施在我地推广了20多年,现在已经在多个地区全面开花了. 今年春季的荔枝、龙眼花期,我县平均单脾产量为5～6.5千克,中蜂群产量在20～30千克,单脾平均产量为5.5～7千克.     

Immune responses and protective efficacy of a recombinant swinepox virus co-expressing HA1 genes of H3N2 and H1N1 swine influenza virus in mice and pigs

The recombinant swine poxvirus rSPV/H3-2A-H1 co-expressing HA1 genes of H3N2 and H1N1 subtype SIV has been constructed and identified. Inoculations of rSPV/H3-2A-H1 yielded ELISA and neutralization antibodies against SIV H1N1 and H3N2, and elicited potent H1N1 and H3N2 SIV-specific INF-γ response from T-lymphocytes in mice and pigs in this study. Complete protection against SIV H1N1 or H3N2 challenge in pigs was observed.     

海南坡鹿疾病发生的一般规律与防治对策

掌握海南坡鹿疾病发生与发展规律,有利于开展防治工作,促进种群恢复.根据多年的实践经验与观察,阐述了海南坡鹿普通疾病发生的一般规律:不同年龄的坡鹿个体多发性疾病存在差异;不同季节坡鹿的多发性疾病类型和发病率也不相同,并提出了相应的疾病防治措施与保护建议.     

山羊鼻内腺瘤和腺癌的病理学研究

发生于内蒙古自治区某地的山羊鼻内肿瘤呈地方性流行，临床上病羊初期流出大量浆液性鼻液，随后逐渐出现呼吸困难和鼻塞音，肿瘤可侵犯周围组织引起眼球突出和头颅变形，最后死于窒息。１４例山羊鼻内肿瘤的病理学研究表明，肿瘤起源于筛骨迷路粘膜的腺体（包括浆液腺和粘液腺），组织学上为腺瘤，以后可转变为腺癌，并向周围组织作浸润性生长，未见转移。２例作透射电镜检查见瘤组织有异型性，瘤组织和瘤组织内未见病毒样颗粒。发生     

氟对牛脾淋巴细胞膜ATP酶活性的影响

取健康牛脾脏,常规方法分离培养淋巴细胞,用不同浓度氟化钠（NaF）染毒24h。低渗溶胞法提取细胞膜,检测膜上ATP酶活性。结果显示,与对照组相比较,染氟组淋巴细胞膜ATP酶活性降低,组间差异显著或极显著。表明：氟能抑制牛脾淋巴细胞膜ATP酶活性。     

Immunopathogenic behaviors of canine transmissible venereal tumor in dogs following an immunotherapy using dendritic/tumor cell hybrid

Canine transmissible venereal tumor (CTVT) is a naturally occurring tumor that can be transmitted between dogs via live tumor cell inoculation. It is also a spontaneous self-regression tumor and its behavior is closely related to host immune responses. Since CTVT had been widely used for tumor models in canine cancers, whether this self-regression may overtake the immunity elicited from an exogenous tumor vaccine remains unclear and certainly worthwhile to be investigated. In this study, we used DCs/tumor hybrids as a tumor vaccine to evaluate the CTVT model. We prepared mature allogeneic dendritic cells from bone marrow and then assessed their phenotype (CD80, CD83, CD86, CD1a, CD11c, CD40 and MHC II), antigen uptake and presenting abilities. Fused dendritic cell/CTVT hybrids were then used as a vaccine, administered three times at two-week intervals via subcutaneous injection near the bilateral auxiliary and inguinal lymph nodes. In comparison with unvaccinated dogs (spontaneous regressed group), within a period of 2.5 months, the vaccinations substantially inhibited tumor progression (p<0.05) and accelerated the rate of regression by a mechanism involving amplification of the host tumor-specific adaptive immune responses and NK cytotoxicity (p<0.001). Pathologic examination revealed early massive lymphocyte infiltration resulting in final tumor necrosis. In addition, there are not any detectable effects on routine physical, body temperature or blood chemistry examinations. In conclusion, our data furnishes a reference value showing that CTVT is a model of potential use for the study of immunity elicited by vaccines against tumors, and also enable early-phase evaluation of the dendritic cell/tumor vaccine in terms of raising host immunity.     

Characterization of porcine circovirus type 2 (PCV2) infection in swine lymphocytes using mitogen-stimulated peripheral blood lymphocytes from healthy PCV2-carrier pigs

Information regarding the susceptibility of swine lymphocytes to PCV2 is rather limited. To further explore and characterize the PCV2 infection in swine lymphocytes, an in vitro model using concanavalin A (Con A)-stimulated peripheral blood lymphocytes (PBLs) obtained from clinically healthy PCV2-carrier pigs was introduced. It was found that the PCV2 antigen-containing rate was below 2% in PBLs from healthy PCV2-free pigs following treated simultaneously with Con A and PCV2. However, significantly higher PCV2 antigen- and nucleic acid-containing rates could be seen in Con A-stimulated PBLs from clinically healthy PCV2-carrier pigs. Prior to Con A treatment, both of the PCV2 antigen- and nucleic acid-containing rates in PBLs from healthy PCV2-carrier pigs were less than 1%; however, they reached 22.1+/-5.7% by flow cytometry and 27.1+/-6.5% by in situ hybridization, respectively, at 4-day post-incubation with Con A. Phenotyping of PCV2 antigen-containing cells revealed that PCV2-positive cells could be detected in both T and B lymphocyte populations within which IgM-positive B lymphocytes appeared to have a relatively higher positive rate. The Con A-stimulated PBLs also displayed a significantly higher viral load by the measurement of either PCV2 DNA copy number or viral titer when compared with the non-treated PBLs from healthy PCV2-carrier pigs. The results indicate that PBLs, especially IgM-bearing B lymphocytes, are indeed susceptible to PCV2 infection and PCV2 is capable of replicating in dividing lymphocytes. This activation-induced replication may explain in part the pathogenesis of lymphoid depletion in PMWS-affected pigs.